Defiance Daily Target 2X Long LLY ETF (LLYX)

Assets	$71.53M
Expense Ratio	1.32%
PE Ratio	n/a
Shares Out	4.11M
Dividend (ttm)	n/a
Dividend Yield	n/a
Ex-Dividend Date	n/a
Payout Frequency	n/a
Payout Ratio	n/a

Volume	609,137
Open	17.04
Previous Close	16.85
Day's Range	16.91 - 17.34
52-Week Low	9.60
52-Week High	28.00
Beta	n/a
Holdings	8
Inception Date	Aug 7, 2024

About LLYX

Fund Home Page

The Defiance Daily Target 2X Long LLY ETF (LLYX) is an exchange-traded fund that mostly invests in health care equity. The fund seeks to provide 2x leveraged exposure to the daily share price movement of the Eli Lilly and Company (NYSE: LLY), less fees and expenses. LLYX was launched on Aug 7, 2024 and is issued by Defiance.

• Asset Class: Equity
• Category: Trading--Leveraged Equity
• Stock Exchange: NYSEARCA
• Ticker Symbol: LLYX
• ETF Provider: Defiance

Performance

LLYX had a total return of -34.67% in the past year, including dividends. Since the fund's inception, the average annual return has been -24.82%.